New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL ...
LC3-associated phagocytosis (LAP) is a specialized process for degrading dead cells, microbes or other particles. It plays a ...
I maintain a Hold rating on ImmunityBio as Anktiva shows strong NMIBC data but the commercial uptake remains slow and uncertain. IBRX's Q2 revenues rose to $26.4M, but accumulated losses and lack of ...
Clarivate plc has unveiled the 2025 Citation Laureates. Widely considered a predictor of the Nobel Prizes, this recognition has highlighted the discovery of biomolecular condensates in chemistry and ...
Lymphoma, a blood cancer, disproportionately affects men due to hormonal differences, weaker immune responses, and greater ...
Wheeler Bio will provide integrated process development and cGMP drug substance manufacturing services. Wheeler Bio, a ...
A new blood test method has been published in an international journal to predict the response to immune cancer treatment in ...
Zinc sits at the heart of many bacterial enzymes, so one of our immune system's simplest defenses is to keep zinc out of ...
In a new study published in Nature Communications, researchers from the Linda Crnic Institute for Down Syndrome (Crnic ...
Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with ...
New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody CLYM116 Phase 1 trial initiation expected in Q4 2025, with init ...